MHRA and US FDA Confirmed to Speak at Controlled Release 2016
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature case studies from an array of global pharmaceutical companies including GSK, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Diurnal and more.
London, United Kingdom, January 30, 2016 --(PR.com)-- SMi's 13th annual Controlled Release conference will provide the ideal platform to receive updates on the latest innovations to accelerate commercialisation, as well as developments in the regulatory landscape to ensure strict compliance. The two-day programme is packed with unmissable case studies provided by GlaxoSmithKline, MHRA, US FDA, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Critical Pharmaceuticals, Kashiv Pharma, Diurnal and more.
Furthermore, SMi is proud to announce that the MHRA and the US FDA will be sharing case studies at the 13th annual Controlled Release, taking place on 18th - 19th April 2016 in London, UK:
MHRA's Pharmaceutical Assessor, Marion Westwood, will share an opening address on Day One titled, 'Supporting innovation in controlled release and combination products'. Her presentation will cover the following key points:
• Discuss the latest innovations surrounding controlled release
• Gain key regulatory updates from leading competent authorities talking specifically on grey areas such as the regulatory environment surrounding combination products
• Case study on work with OxSonics
US FDA's Pharmacologist, Mohammad Absar, will be delivering a presentation at 13:50 on Day One titled 'Regulatory perspective on innovative systems for controlled release'. Key points covered include:
• An overview of current innovative controlled release systems in the US market
• Scientific and regulatory challenges in developing generic controlled release systems
• FDA/OGD’s ongoing research program
Key speakers at SMi's 13th annual Controlled Release conference includes:
• David Elder, Due Diligence Director, GlaxoSmithKline
• Andy Lewis, Director Novel Drug Delivery Technologies, Ipsen
• Sachin Mittal, Senior Principal Scientist, Merck
• Marianne Ashford, Principal Scientist Drug Targeting, AstraZeneca
• Sune Andersen, Principal Scientist, Novo Nordisk
To view the full speaker line-up and conference programme, visit http://www.controlledrelease.co.uk/prcom
Furthermore, SMi is proud to announce that the MHRA and the US FDA will be sharing case studies at the 13th annual Controlled Release, taking place on 18th - 19th April 2016 in London, UK:
MHRA's Pharmaceutical Assessor, Marion Westwood, will share an opening address on Day One titled, 'Supporting innovation in controlled release and combination products'. Her presentation will cover the following key points:
• Discuss the latest innovations surrounding controlled release
• Gain key regulatory updates from leading competent authorities talking specifically on grey areas such as the regulatory environment surrounding combination products
• Case study on work with OxSonics
US FDA's Pharmacologist, Mohammad Absar, will be delivering a presentation at 13:50 on Day One titled 'Regulatory perspective on innovative systems for controlled release'. Key points covered include:
• An overview of current innovative controlled release systems in the US market
• Scientific and regulatory challenges in developing generic controlled release systems
• FDA/OGD’s ongoing research program
Key speakers at SMi's 13th annual Controlled Release conference includes:
• David Elder, Due Diligence Director, GlaxoSmithKline
• Andy Lewis, Director Novel Drug Delivery Technologies, Ipsen
• Sachin Mittal, Senior Principal Scientist, Merck
• Marianne Ashford, Principal Scientist Drug Targeting, AstraZeneca
• Sune Andersen, Principal Scientist, Novo Nordisk
To view the full speaker line-up and conference programme, visit http://www.controlledrelease.co.uk/prcom
Contact
SMi Group
Vinh Trinh
+44 (0) 207 827 6140
http://www.controlledrelease.co.uk/prcom
Vinh Trinh
+44 (0) 207 827 6140
http://www.controlledrelease.co.uk/prcom
Contact
Categories